Option Care Health (NASDAQ:OPCH) Price Target Cut to $32.00 by Analysts at Barrington Research

Option Care Health (NASDAQ:OPCH - Get Free Report) had its price objective dropped by equities researchers at Barrington Research from $40.00 to $32.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Barrington Research's price target points to a potential upside of 38.89% from the company's previous close.

Other research analysts have also recently issued reports about the stock. Jefferies Financial Group cut shares of Option Care Health from a "buy" rating to a "hold" rating and decreased their price objective for the company from $38.00 to $26.00 in a report on Thursday. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a report on Monday, September 30th. Finally, Bank of America cut shares of Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.51 on Thursday, hitting $23.04. The company had a trading volume of 5,124,136 shares, compared to its average volume of 1,445,897. The business has a 50-day simple moving average of $30.81 and a 200-day simple moving average of $30.02. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36. The company has a market cap of $3.94 billion, a PE ratio of 19.75, a PEG ratio of 2.31 and a beta of 1.29. Option Care Health has a 52 week low of $22.84 and a 52 week high of $34.63.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. The business had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.22 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. Research analysts expect that Option Care Health will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company's stock, valued at approximately $663,429.51. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company's stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Harbor Capital Advisors Inc. raised its holdings in shares of Option Care Health by 115.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 207,560 shares of the company's stock valued at $6,497,000 after purchasing an additional 111,185 shares in the last quarter. Janney Capital Management LLC bought a new position in shares of Option Care Health during the 3rd quarter valued at $362,000. Congress Asset Management Co. raised its holdings in shares of Option Care Health by 20.9% during the 3rd quarter. Congress Asset Management Co. now owns 341,602 shares of the company's stock valued at $10,692,000 after purchasing an additional 58,972 shares in the last quarter. Diversify Wealth Management LLC raised its holdings in shares of Option Care Health by 15.3% during the 3rd quarter. Diversify Wealth Management LLC now owns 10,299 shares of the company's stock valued at $309,000 after purchasing an additional 1,364 shares in the last quarter. Finally, Pinnacle Associates Ltd. raised its holdings in shares of Option Care Health by 11.6% during the 3rd quarter. Pinnacle Associates Ltd. now owns 30,066 shares of the company's stock valued at $1,013,000 after purchasing an additional 3,137 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.